S-nitrosoglutathione photolysis as a novel therapy for antifibrosis in filtration surgery

Investigative Ophthalmology and Visual Science

Volumn 41, Issue 3, 2000, Pages 749-755

  Tannous, Marie ^c   Hutnik, Cindy M L ^a   Tingey, David P ^a   Mutus, Bulent ^b  

^a LONDON HEALTH SCIENCES CENTRE   (Canada)

^b UNIVERSITY OF WINDSOR   (Canada)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; S NITROSOGLUTATHIONE;

ANIMAL CELL; ARTICLE; CELL DEATH; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; FIBROSIS; FILTERING OPERATION; GLAUCOMA; HUMAN; HUMAN CELL; NONHUMAN; PHOTOLYSIS; PRIORITY JOURNAL;

AMINOLEVULINIC ACID; ANIMALS; CELL DEATH; CELL DIVISION; CELL LINE; CRICETINAE; CRICETULUS; FASCIA; FIBROBLASTS; FIBROSIS; FILTERING SURGERY; GLUTATHIONE; HUMANS; LUNG; MICROSCOPY, CONFOCAL; NITROSO COMPOUNDS; PHOTOCHEMOTHERAPY; PHOTOLYSIS; PHOTOSENSITIZING AGENTS; S-NITROSOGLUTATHIONE;

EID: 0034055784     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Jampel HD, McGuigan LJB, Dunkelberger MS, l'Hernault NL, Quigley HA. Cellular proliferation after experimental glaucoma filtration surgery. Arch Ophthalmol. 1988;106:89-94.
2. Desjardins DC, Parrish RK, Folberg R, Nevarez J, Heuer DK, Gressel MG. Wound healing after filtering surgery in owl monkeys. Arch Ophthalmol. 1986;104:1835-1839.
3. Addicks EM, Quigley HA, Green R, Robin HL. Histologic characteristics of filtering blebs in glaucomatous eyes. Arch Ophthalmol. 1983;101:795-798.
4. Van Buskirk EM. Five-year follow-up of the fluorouracil filtering surgery study. Am J Ophthalmol. 1996;121:349-366.
5. Kitazawa Y, Kawase K, Matsushita H, Minobe M. Trabeculectomy with mitomycin: a comparative study with fluorouracil. Arch Ophthalmol. 1991;109:1693-1698.
6. Zacharia PT, Deppermann, SR, Schuman JS. Ocular hypotony after trabeculectomy with mitomycin C, Am J Ophthalmol. 1993;116: 314-326.
7. Greenfield DS, Suner IJ, Miller MP, Kangas TA, Palmberg PF, Flynn HW. Endophthalmitis after filtering surgery with mitomycin Arch Ophthalmol. 1996;114:943-949.
8. Wolner B, Liebmann JM, Sassani JW, Ritch R, Speaker M, Marmor M. Late bleb-related endophthalmitis after trabeculectomy with adjunctive 5-fluorouracil. Ophthalmology. 1991;98:1053-1060.
9. Megevand GS, Salmon JF, Scholtz R, Murray AND. The effect of reducing the exposure time of mitomycin C in glaucoma filtering surgery. Ophthalmology. 1995;102:84-90.
10. Fisher AMR, Ferrario A, Gomer CJ. Adriamycin resistance in Chinese hamster fibroblasts following oxidative stress induced by photodynamic therapy. Photochem Photobiol. 1993;58:581-588.
11. Fritsch C, Goerz G, Ruzicka T. Photodynamic therapy in dermatology. Arch Dermatol. 1998;134:207-214.
12. Kim RY, Hu LK, Foster BS, Gragoudas ES, Young LH. Photodynamic therapy of pigmented choroidal melanomas of greater than 3 mm thickness. Ophthalmology. 1996;103:2029-2036.
13. Thomas EL, Rosen R, Murphy R, et al. Purlytin (SnET2)-photodynamic therapy produces closure of subfoveal choroidal neovascularization in humans [ARVO Abstract]. Invest Ophthalmol Vis Sci. 1998;39(4):S242. Abstract nr 1105.
14. Bressler NM. Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Investigation using verteporfin (BPD-MA): baseline characteristics and safety [ARVO Abstract]. Invest Ophthalmol Vis Sci. 1998;39(4):S242. Abstract nr 1104.
15. Noodt BB, Berg K, Stokke T, Peng Q, Nesland JM. Apoptosis and necrosis induced with light and 5-aminolevulinic acid-derived protoporphyrin IX. Br J Cancer. 1996;74:22-29.
16. Berg K, Anholt H, Bech O, Moan J. The influence of iron chelators on the accumulation of protoporphyrin IX in 5-aminolevulinic acid-treat cells. Br J Cancer. 1996;74:688-697.
17. Krammer B, Uberriegler K. In-vitro investigation of ALA-induced protoporphyrin IX. J Photochem Photobiol B. 1996;36:121-126.
18. Smyth RJ, Nguyen K, Ahn SS, Panek WC, Lee DA. The effects of Photofrin on human Tenon's capsule fibroblasts in vitro. J Ocul Pharmacol. 1993;9:171-178.
19. Hill RA, Crean DH, Doiron DR, et al. Photodynamic therapy for antifibrosis in a rabbit model of filtration surgery. Ophthalmic Surg Lasers. 1997;28:574-581.
20. Wood PD, Mutus B, Redmond RW. The mechanism of photochemical release of nitric oxide from S-nitrosoglutathione. Photochem Photobiol. 1996;64:518-524.
21. Bown SG. Photodynamic therapy to scientists and clinicians: one world or two? J Photochem Photobiol B. 1990;6:1-12.
22. Fisher AMR, Murphree AL, Gomer CJ. Clinical and preclinical photodynamic therapy. Lasers Surg Med. 1995;17:2-31.
23. Kennedy JC, Pottier RH. Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. J Photochem Photobiol B. 1992;14:275-292.
24. Henderson BW, Dougherty TJ. How does photodynamic therapy work? Photochem Photobiol. 1992;55:145-157.
25. Evans CH. Nitric oxide: what role does it play in inflammation and tissue destruction? In: Inflammation Mechanisms and Therapeutics. Basel, Switzerland: Birkhauser Verlag; 1995:107-116.
26. Sexton DJ, Muruganandam A, McKenney DJ, Mutus B Visible light photochemical release of nitric oxide from S-nitrosoglutathione: potential photochemotherapeutic applications. Photochem Photobiol. 1994;59:463-467.
27. Mutus B, Redmond RW, Akhter S. Evidence for the production of peroxynitrite during S nitrosoglutathione photolysis in aerated solutions. FEBS Lett. 1999;449:79-82.